|CUR -- Germany Stock|| |
EUR 0.95 0.012 1.25%
Mr. Richard J. Daly is Chairman of the Board President Chief Executive Officer of the company. He has over 25 years of commercial pharmaceutical experience working in positions of progressive responsibility in sales marketing and operations. From November 2015 until February 2016 Mr. Daly was a managing partner at Ravine Rock Partners LLC a biopharmaceutical consulting company. Prior to that from August 2013 until November 2014 Mr. Daly was the President of U.S. Diabetes a subsidiary of AstraZeneca Pharmaceutical LP. From October 2011 until November 2012 Mr. Daly was a founding partner board member and investor in SagePath Partners LLC a commercial outsourcing provider to the pharmaceutical industry. Between July 2008 and October 2011 Mr. Daly was executive vice president of North and South America for Takeda NA the north American subsidiary of Takeda Pharmaceuticals . Since June 2015 Mr. Daly has served on the board of directors and on the Compensation and Commercial Committees for Synergy Pharmaceuticals . Since February 2015 Mr. Daly has also served on the board of directors and on the Compensation Committee of Catalyst Pharmaceuticals
Age: 61 CEO Since 2016 MBA
49 6027 40 900 51 http://www.curasan.de
Daly holds a BS in Microbiology from The University of Notre Dame and an MBA from Northwestern University Kellogg Graduate School of Management.